Interferon induction in turkeys by oral administration of the imidazoquinolinamine S-28828 and modulation of the pathogenesis of Escherichia coli

Veterinary Immunology and Immunopathology

Volumn 66, Issue 2, 1998, Pages 127-141

  Rautenschlein, Silke ^a   Miller, Richard L ^b   Sharma, Jagdev M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b 3M COMPANY   (United States)

Author keywords

Escherichia coli; Imiquimod; Immunomodulation; Interferon; Macrophages; Turkeys

Indexed keywords

1 N BUTYL 2 ETHOXYMETHYL 1H IMIDAZO[4,5 C]QUINOLIN 4 AMINE; CYTOKINE; IMIDAZOQUINOLINE DERIVATIVE; INTERFERON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ESCHERICHIA COLI; IMMUNOMODULATION; INTERFERON PRODUCTION; MORTALITY; NONHUMAN; PATHOGENESIS; SHOCK; SPLEEN CELL; TURKEY (BIRD);

ADMINISTRATION, ORAL; AMINOQUINOLINES; ANIMALS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOPATHOGENIC EFFECT, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI INFECTIONS; FLOW CYTOMETRY; HEAT; HYDROGEN-ION CONCENTRATION; INTERFERON INDUCERS; INTERFERON TYPE I; MALE; POULTRY DISEASES; RANDOM ALLOCATION; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TURKEYS;

EID: 0032564402     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00197-4     Document Type: Article

References (44)

1. Alam J.J. Interferon-β treatment of human disease. Curr. Opin. Biotech. 6:1995;688-691.
2. Arp L.H., Cheville N.F. Interaction of blood-borne Escherichia coli with phagocytes of spleen and liver in turkeys. Am. J. Vet. Res. 42:1981;650-657.
3. Bernstein D.I., Harrison C.J. Effect of immunomodulating agent R-837 on acute and latent herpes simplex virus type 2 infections. Antimicrob. Agents and Chemother. 33:1989;1511-1515.
4. Bernstein, D.I., Miller, R.L., Harrison, C.J., 1991. Effect of R-837 (an immunomodulator) and acyclovir on genital HSV infection when begun after lesion development in the guinea pig, Abstr. of ASM, Interscience Conf. Antimicrobial Agents and Chemotherapy, Chicago, IL, 304 pp.
5. Bernstein D.I., Miller R.L., Harrison C.J. Effects of the immunomodulator (imiquimod, R-837) alone and with acyclovir on gential HSV-2 infection in guinea pigs when begun after lesion development. Antiviral Res. 20:1993;45-55.
6. Borden E.C., Sidky Y.A., Weeks C.E. Mechanisms of anti-tumor action of the interferon inducer R-837. Proc. Am. Assoc. Cancer Res. 32:1991;258.
7. Cardi, G., Ciardelli, T.L., Ernstoff, M.S., 1996. Therapeutic applications of cytokines for immunostimulation and immunosuppression: An update, In: Jucker, E. (Ed.), Progress in Drug Research, Birkhäuser Verlag, Basel, pp. 211-250.
8. Cheville N.F., Arp L.H. Comparative pathologic findings of Escherichia coli infection in birds. J. Am. Vet. Med. Assoc. 173:1978;584-587.
9. Chirigos M.A. Immunomodulators: Current and future development and application. Thymus. 19:1992;S7-S20.
10. De Maeyer, E.M., De Maeyer-Guignard, J., 1988. Macrophages as interferon producers and interferons as modulators of macrophage activity, In: Interferons and Other Regulatory Cytokines, Wiley Interscience, New York, pp. 194-219.
11. Digby M.R., Lowenthal J.W. Cloning and expression of the chicken interferon-γ gene. J. Interferon Cytokine Res. 15:1995;933-938.
12. Eron L.J., Harvey L., Toy C., Santomaruo D. Interferon in the prevention of genital herpes recurrence. Antimicrob. Agents Chemother. 30:1986;608-610.
13. Ficken M.D., Edwards J.F., Lay J.G. Induction, collection, and partial characterization of induced respiratory macrophages of the turkey. Avian Dis. 30:1986;766-771.
14. Gibson S.J., Imbertson L.M., Wagner T.L., Testerman T.L., Reiter M.J., Miller R.L., Tomai M.A. Cellular requirement for cytokine production in response to the immunomodulators imiquimod and S-27609. J. Interferon Cytokine Res. 15:1995;537-545.
15. Gross, W.B., 1991. Colibacillosis, In: Calnek, B.W., Barnes, H.J., Beard, C.W., Reid W.M., Yoder, H.W. Jr. (Eds.), Diseases of Poultry, 9th edn., Iowa State University Press, Ames, IA, pp. 138-144.
16. Hadden J.W. Immunostimulants. Immunol. Today. 14:1993;275-280.
17. Harmon B.G., Glisson J.R. Disassociation of bactericidal and fungistatic activities from the oxidative burst of avian macrophages. Am. J. Vet. Res. 51:1990;71-75.
18. Harrison C.J., Jenski L., Voychehovski T. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection. Antiviral Res. 10:1988;209-224.
19. Harrison C.J., Rison C.J., Stanberry L.R., Bernstein D.I. Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs. Antiviral Res. 15:1991;315-322.
20. Karaca K., Sharma J.M., Tomai M.A., Miller R.L. In vivo and in vitro interferon induction in chickens by S-28828, an imidazoquinolinamine immunoenhancer. J. Interferon Cytokine Res. 16:1996;327-332.
21. Kuhls T.L., Sacher J., Pindea E. Suppression of recurrent genital herpes simplex virus infection with recombinant alpha interferon. J. Infect. Dis. 154:1986;437-442.
22. Leitner G., Heller E.D. Colonization of Escherichia coli in young turkeys and chickens. Avian. Dis. 36:1992;211-220.
23. Leitner G., Heller E.D., Friedman A. Sex-related differences in immune response and survival rate of broiler chickens. Vet. Immunol. Immunopathol. 21:1989;249-269.
24. Lillehoj H.S., Kaspers B., Jenkins M.C., Lillehoj E.P. Avian interferon and interleukin-2. A review by comparison with mammalian homologs. Poult. Sci. Rev. 4:1992;67-85.
25. Miles, A.M., Doelling, V.W., Phelps, P.V., Ricks, C.A., Tyczkowski, J.K., Whitfill, C.E., Gildersleeve, R.P., 1993. Efficacy of an immunostimulant administered in ovo, Proc. Xth Int. Cong. World Poultry Association, Sydney, Australia, 161 pp.
26. Miller, R.L., Imberston, L.M., Reiter, M.J., Schwartzmiller, D.H., Pecore, S.E., Gerster, J.F., 1985. Inhibition of herpes simplex virus infection in a guinea pig model by S-26308 (Abstr.), ASM, 26th Interscience Conf. Antimicrobial Agents and Chemotherapy, 235 pp.
27. Miller R., Birmchu W., Gerster J., Gibson S., Imbertson L., Reiter M., Scribner L., Wagner T., Weeks C., Tomai M. Imiquimod: Cytokine induction and antiviral activity. Int. Antiviral News. 3:1995;111-113.
28. Olmos L., Vilta J., Rodriguea-Pichardo A., Lloret A., Ojeda A. Double blind, randomized clinical trial on the effect of interferon-beta in the treatment of condylomata acuminata. Int. J. Sex. Transmitt. Dis. AIDS. 5:1994;182-185.
29. Persson-Waller K., Colditz I.G., Seow H.-F. Accumulation of leukocytes and cytokines in the lactating ovine udder during mastitis due to Staphylococcus aureus and Escherichia coli. Res. Vet. Med. 62:1997;63-66.
30. Pertile T.L., Karaca K., Walser M.M., Sharma J.M. Suppressor macrophage mediated depressed lymphoproliferation in chickens infected with avian reovirus. Vet. Immunol. Immunopathol. 53:1996;129-145.
31. Rasnitzky D., Tiefbrun N., Berissi H., Kimchi A. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth sensitive hematopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 89:1992;402-406.
32. Rautenschlein, S., 1994. Ontogenetische Studie zur Empgfänglichkeit von Pute und Hun für das Virus der Hämorrhagischen Enteritis (HEV), Hannover, Tieräztliche Hochschule, Dissertation.
33. Reiter M.J., Testerman T.L., Miller R.L., Weeks C.E., Tomai M.A. Cytokine induction in mice by the immunomodulator imiquimod. J. Leuk. Biol. 55:1994;234-240.
34. Russala-Mallon V., Lin Y.-I., Durr F.E., Wang B.S. Low molecular weight immunopotentiators. Int. J. Immunopharmacol. 10:1987;497-510.
35. Sekellik M.J., Marcus P.I. Induction of high titer chicken interferon. Methods Enzymol. 119:1986;115-125.
36. Sekellick M.J., Ferrandino A.F., Hopkins D.A., Marcus P.I. Chicken interferon gene: Cloning, expression and analysis. J. Interferon Res. 14:1994;71-79.
37. Sen G.C., Lengyel P. The interferon system. J. Biol. Chem. 267:1992;5017-5020.
38. Sidky Y.A., Borden E.C., Weeks C.E., Reiter M.J., Hatcher J.F., Bryan G.T. Inhibition of murine tumor growth by an interferon inducing imidazoquinolinamine. Cancer Res. 52:1992;3528-3533.
39. Spónenberg D.P., Domermuth C.H., Larsen C.T. Field outbreaks of colibacillosis of turkeys associated with hemorrhagic enteritis virus. Avian Dis. 29:1985;838-842.
40. Suresh M., Sharma J.M., Belzer S.W. Studies on lymphocyte subpopulations and the effect of age on immune competence in turkeys. Dev. Comp. Immunol. 17:1993;525-535.
41. Suresh M., Karaca K., Foster D., Sharma J.M. Molecular and functional characterization of turkey interferon. J. Virol. 69:1995;8159-8163.
42. Suresh et al., 1996.
43. Suzuki H., Nichigaki K., Gunji A. Treatment of chronic non-A, non-B hepatitis with human interferon-β, a randomized controlled trial with different durations. Kan Tan Sui. 23:1994;1065-1079.
44. Weeks C.E., Gibson S.J. Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cell in vitro. J. Interferon Res. 141:1993;81-85.